---
title: "Bristol Myers Squibb will pay up to $11.1 billion to a biotech company in a cancer collaboration dea"
description: "Bristol Myers Squibb will pay up to $11.1 billion to a biotech company in a cancer collaboration deal"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/242776118.md"
published_at: "2025-06-02T10:45:30.000Z"
---

# Bristol Myers Squibb will pay up to $11.1 billion to a biotech company in a cancer collaboration dea

> Bristol Myers Squibb will pay up to $11.1 billion to a biotech company in a cancer collaboration deal

Bristol Myers Squibb will pay up to $11.1 billion to a biotech company in a cancer collaboration deal

### Related Stocks

- [BMY.US - Bristol Myers Squibb](https://longbridge.com/en/quote/BMY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Salesforce CEO Marc Benioff's ICE joke was delivered at a difficult time for his company | Salesforce CEO Marc Benioff's ICE joke was delivered at a difficult time for his company | [Link](https://longbridge.com/en/news/275896154.md) |
| AB Inbev CFO Fernando Tennenbaum: 2026 will hopefully be a more normal year on costs, we see further opportunities to expand margin | AB Inbev CFO Fernando Tennenbaum: 2026 will hopefully be a more normal year on costs, we see further opportunities to ex | [Link](https://longbridge.com/en/news/275819045.md) |
| Behind the Scenes of Albemarle's Latest Options Trends | Deep-pocketed investors are showing a bullish trend towards Albemarle (NYSE:ALB), with 28 significant options activities | [Link](https://longbridge.com/en/news/275787820.md) |
| Albemarle CEO: Acquisitions 'not really our focus at this point in the cycle' | Albemarle CEO Kent Masters stated that acquisitions are not a priority for the company at this stage. He highlighted a p | [Link](https://longbridge.com/en/news/275768490.md) |
| Atria Investments Inc Has $13.65 Million Holdings in PepsiCo, Inc. $PEP | Atria Investments Inc reduced its stake in PepsiCo, Inc. (NASDAQ: PEP) by 9.3% in Q3, holding 97,185 shares valued at ap | [Link](https://longbridge.com/en/news/275870124.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.